<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36902702</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Very Long COVID: Persistence of Symptoms after 12-18 Months from the Onset of Infection and Hospitalization.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1915</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12051915</ELocationID><Abstract><AbstractText>According to the World Health Organization's definition, long COVID is the persistence or development of new symptoms 3 months after the initial infection. Various conditions have been explored in studies with up to one-year follow-up but very few looked further. This prospective cohort study addresses the presence of a wide spectrum of symptoms in 121 patients hospitalized during the acute phase of COVID-19 infection, and the association between factors related to the acute phase of the disease and the presence of residual symptoms after one year or longer from hospitalization. The main results are as follows: (i) post-COVID symptoms persist in up to 60% of the patient population at a mean follow-up of 17 months; (ii) the most frequent symptoms are fatigue and dyspnea, but neuropsychological disturbances persist in about 30% of the patients (iii) when corrected for the duration of follow-up with a freedom-from-event analysis; only complete (2 doses) vaccination at the time of hospital admission remained independently associated with persistence of the major physical symptoms, while vaccination and previous neuropsychological symptoms remained independently associated with persistence of major neuropsychological symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4915-3572</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baryshnikova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anguissola</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7132-2782</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8168-8254</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falco</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, Koelliker Hospital, 10134 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menicanti</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Scientific Directorate, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Not applicable</GrantID><Agency>Ministry of Health of Italy</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long follow-up</Keyword><Keyword MajorTopicYN="N">major neurological symptoms</Keyword><Keyword MajorTopicYN="N">major physical symptoms</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-acute</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funding organization had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36902702</ArticleId><ArticleId IdType="pmc">PMC10003916</ArticleId><ArticleId IdType="doi">10.3390/jcm12051915</ArticleId><ArticleId IdType="pii">jcm12051915</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Post COVID-19 Condition (Long COVID)  [(accessed on 7 January 2023)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-Day Outcomes Among Patients Hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L.C., Kemp S., Corrado J., Singh R., Collins T., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli L., Raimondi F., Carioli G., Carobbio A., Pappacena S., Biza R., Trapasso R., Anelli M., Amoroso M., Allegri C., et al. HPG23 Covid19 Study Group. One-year mortality in COVID-19 is associated with patients&#x2019; comorbidities rather than pneumonia severity. Respir. Med. Res. 2022;83:100976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9691276</ArticleId><ArticleId IdType="pubmed">36473331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz L., Ar&#xe9;valos V., Fern&#xe1;ndez-Rodr&#xed;guez D., Jim&#xe9;nez-D&#xed;az V., Ba&#xf1;eras J., Campo G., Rodr&#xed;guez-Santamarta M., D&#xed;az J.F., Scardino C., G&#xf3;mez-&#xc1;lvarez Z., et al. CV COVID-19 registry investigators. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry. PLoS ONE. 2022;17:e0279333. doi: 10.1371/journal.pone.0279333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0279333</ArticleId><ArticleId IdType="pmc">PMC9803130</ArticleId><ArticleId IdType="pubmed">36583998</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., So M., Iwagami M., Fukunaga K., Takagi H., Kabata H., Kuno T. One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysis. Respirology. 2022;27:605&#x2013;616. doi: 10.1111/resp.14311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14311</ArticleId><ArticleId IdType="pmc">PMC9350074</ArticleId><ArticleId IdType="pubmed">35694728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaco S., Sousa G., Gon&#xe7;alves A., Dias A., Andrade C., Pereira D., Aires E.A., Moura J., Silva L., Varela R., et al. Predictors of cognitive dysfunction one-year post COVID-19. Neuropsychology. 2023. epub ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/neu0000876</ArticleId><ArticleId IdType="pubmed">36603126</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalak G., Jarjou&#x2019;i A., Bohadana A., Wild P., Rokach A., Amiad N., Abdelrahman N., Arish N., Chen-Shuali C., Izbicki G. Prevalence and Persistence of Symptoms in Adult COVID-19 Survivors 3 and 18 Months after Discharge from Hospital or Corona Hotels. J. Clin. Med. 2022;11:7413. doi: 10.3390/jcm11247413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247413</ArticleId><ArticleId IdType="pmc">PMC9784691</ArticleId><ArticleId IdType="pubmed">36556030</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Canales L.G., Mu&#xf1;oz-Corona C., Barrera-Ch&#xe1;vez I., Viloria-&#xc1;lvarez C., Mac&#xed;as A.E., Guan&#xed;-Guerra E. Quality of Life and Persistence of Symptoms in Outpatients after Recovery from COVID-19. Medicina. 2022;58:1795. doi: 10.3390/medicina58121795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58121795</ArticleId><ArticleId IdType="pmc">PMC9781541</ArticleId><ArticleId IdType="pubmed">36556998</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun M.C., Singh A.K., Pal D., Das K., Alekhya G., Venkateshan M., Mishra B., Patro B.K., Mohapatra P.R., Subba S.H. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS ONE. 2022;17:e0278825. doi: 10.1371/journal.pone.0278825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>UKHSA Review Shows Vaccinated Less Likely to Have Long COVID than Unvaccinated.  [(accessed on 13 January 2022)]; Available online:  https://www.gov.uk/government/news/ukhsa-review-shows-vaccinated-less-likely-to-have-long-covid-than-unvaccinated.</Citation></Reference><Reference><Citation>Romero-Rodr&#xed;guez E., P&#xe9;rula-de Torres L.&#xc1;., Castro-Jim&#xe9;nez R., Gonz&#xe1;lez-Lama J., Jim&#xe9;nez-Garc&#xed;a C., Gonz&#xe1;lez-Bernal J.J., Gonz&#xe1;lez-Santos J., V&#xe9;lez-Santamar&#xed;a R., S&#xe1;nchez-Gonz&#xe1;lez E., Santamar&#xed;a-Pel&#xe1;ez M. Hospital admission and vaccination as predictive factors of long COVID-19 symptoms. Front. Med. 2022;9:1016013. doi: 10.3389/fmed.2022.1016013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1016013</ArticleId><ArticleId IdType="pmc">PMC9691755</ArticleId><ArticleId IdType="pubmed">36438042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Apostolo D., Alb&#xe8; A., Crevola M., Errica N., Ratano G., Tonello S., Minisini R., D&#x2019;Onghia D., Baricich A., et al. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study. Front. Immunol. 2022;13:1038227. doi: 10.3389/fimmu.2022.1038227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1038227</ArticleId><ArticleId IdType="pmc">PMC9807078</ArticleId><ArticleId IdType="pubmed">36601115</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunvoll S.H., Nygaard A.B., Fagerland M.W., Holland P., Ellingjord-Dale M., Dahl J.A., S&#xf8;raas A. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection. Int. J. Infect. Dis. 2023;126:10&#x2013;13. doi: 10.1016/j.ijid.2022.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.11.009</ArticleId><ArticleId IdType="pmc">PMC9651990</ArticleId><ArticleId IdType="pubmed">36375693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>